Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a leg pump prevent clots in Bleeding-Prone patients?

NCT ID NCT00740844

Prevention Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding a leg compression device to elastic stockings reduces blood clots in intensive care patients at high risk of bleeding. Over 400 patients were randomly assigned to receive either the device plus stockings or stockings alone. The main goal was to see if the combination lowered the number of blood clots in the legs or lungs by day 6.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intermittent pneumatic compression device
What this could lead to
If it works, this could provide a safer way to prevent dangerous blood clots in patients who cannot take blood thinners.
What could go wrong
This is a completed Phase 3 trial, but results may not apply to all hospital settings. The device may cause discomfort or skin issues, and the benefit over stockings alone may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

408 people

The number who actually took part.

Start date

Nov 2007

Finished

Dec 2011

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 18 Years, * Admission in intensive medical care unit * High risk for hemorrhage * Written informed consent given by the patient or relative. High risk for hemorrhage is defined by: * symptomatic bleeding or organic lesions likely to bleed, * hemophilic diseases, * haemostatic abnormalities: platelet count \< 50 000/mm 3, APTT \> 2 N, prothrombin time \< 40%, * recent intra-cerebral hemorrhage, * severe anemia (Hemoglobin \< 7 g/dl) due to a bleeding or unexplained. Exclusion Criteria: * Age \< 18 years, * Patient refusal, * No high risk for hemorrhage * Admission in intensive care unit ≥ 36 hours * Admission in intensive care unit likely for \< 72 hours * A "do not resuscitate" order * IPC contra-indication: Recent DVT (\< 3 month), severe lower limbs arteriopathy (III and IV), any arterial graft of the legs, a wound in the lower limb related either to a vascular disease (ulcer) or a trauma. * Patient with mechanical prosthetic heart valve.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hemorrhage venous thromboembolism prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemorrhage High bleeding risk

Contacts and locations

Locations

  • HIA Clermont-Tonnerre

    Brest, 29 000, France

  • Intensive Care Unit

    Limoges, France

  • Medical Intensive Care Unit

    Brest, France

  • Medical Intensive Care Unit

    Lille, France

  • Medical Intensive Care Unit

    Nantes, France

  • Medical Intensive Care Unit

    Paris, France

  • Medical intensive care unit

    Angoulême, France

  • Medical intensive care unit

    Orléans, France

  • Medical intensive care unit

    Poitiers, France

  • Medical intensive care unit

    Tours, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.